Architecting Enterprise AI for Generative and Agentic Systems – with Ranjan Sinha of IBM
Maintaining legacy IT platforms has become a massive financial and operational drag. Research from Pegasystems Inc., in partnership with research firm…

•


Read the Emerj team’s latest coverage on AI use-cases and trends in banking.
Maintaining legacy IT platforms has become a massive financial and operational drag. Research from Pegasystems Inc., in partnership with research firm…

•

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

•

Across regulated and asset-intensive industries, AI adoption is shaped by factors beyond technical feasibility. Organizations now seek to deploy AI systems…

•

Bristol Myers Squibb is a global biopharmaceutical leader dedicated to delivering innovative medicines across oncology, hematology, immunology, cardiovascular disease, and neuroscience.…

•

This article is sponsored by NLP Logix and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

•

This interview analysis is sponsored by AnswerRocket and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…

•

Clinical trials comprise the most significant portion of drug development costs. In some cases, drug R&D costs can approach as high…

•
